Clinical Outcomes supported ReQoL’s inclusion in a major international handbook, showcasing its global reach through rigorous translation, linguistic validation, and cultural adaptation processes.
Oxford University Innovation’s Clinical Outcomes team offers validated tools to assess mental health across diverse populations - from individuals with depression and children with anxiety, to those in forensic psychiatric care. These tools support informed interventions, improve service delivery, and better health outcomes.
Oxford University Innovation's Clinical Outcome team will be attending ISPOR 2025 in Montreal, QC, Canada from 13 - 16 May
Oxford University Innovation's Clinical Outcomes team will be attending Drug Information Association (DIA) Europe 2025, in Basel Switzerland from 18th-20th March.
Oxford University Innovation’s Clinical Outcomes team offers validated assessment tools that capture patient experiences in gastroenterology, nutrition, and dietetics. These insights help clinicians and researchers enhance patient-centered care, improve health outcomes, and shape better healthcare policies.
Oxford University Innovation's Clinical Outcome team will be attending ISPOR Europe 2024 in Barcelona, Spain from the 17th - 20th November.
Vasculitis is a complex and unpredictable disease, primarily caused by inflammation of the blood vessels.
Oxford University Innovation's Clinical Outcome team will be attending and presenting at the annual ISOQOL 2024 conference in Cologne, Germany from the 13th - 16th October 2024.
The Steroid PRO is now available to licence through the Clinical Outcomes team at Oxford University Innovation.
